Publications by authors named "April Armstrong"

Claim this Profile
S
Supporting evidence and recommendations for the management of patients with systemic-eligible atopic dermatitis: A Canadian consensus document.
Kerri Purdy, Melinda Gooderham, Mohannad Abu-Hilal, April Armstrong, Rachel Asiniwasis

JAAD Int· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flexure-Based Locking Plates Can Modulate Interfragmentary Motion in Distal Femur and Diaphyseal Fractures: A Parametric Finite Element Analysis.
Connor Huxman, Gary Updegrove, April Armstrong, Hwabok Wee, Mary I Frecker

J Biomech Eng· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An atypical case of pemphigus herpetiformis with erythroderma.
Charlotte Jeong, Peichi P Chou, Elaine Dong, Amy Shen, Shanice McKenzie, April W Armstrong

JAAD Case Rep· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variation in depression risk by race and ethnicity in vitiligo.
Matthew J Yan, Peichi P Chou, Alyssa M Roberts, Charlotte Y Jeong, Nicole Johnsen, April W Armstrong

JAAD Int· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Report From the 2024 International Dermatology Outcome Measures (IDEOM) Annual Meeting.
Sarah Romanelli, Gretchen D Ball, Arianna J Zhang, Christina Asare, Audrey Hao, April W Armstrong

J Drugs Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laboratory monitoring in patients with moderate to severe plaque psoriasis.
Jonathan M Fenkel, John A Osborne, April W Armstrong, Bruce Strober, Linda Stein Gold

J Dermatolog Treat· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in Prescription Patterns Among Various Physician Specialties for Patients with Chronic Spontaneous Urticaria.
Peichi Chou, Elaine Ma, Alyssa Roberts, Charlotte Jeong, Abigail Katz, April Armstrong

J Am Acad Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deucravacitinib in Plaque Psoriasis After Inadequate Response to Apremilast: Phase 3 POETYK Analysis.
April W Armstrong, Richard B Warren, Howard Sofen, Lynda Spelman, Misti Linaberry

Dermatol Ther (Heidelb)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bimekizumab Impact on Patient-Reported Outcomes in Plaque Psoriasis: 4-Year Results from BE SURE, BE VIVID, BE READY, and BE BRIGHT.
April Armstrong, Kim A Papp, Mark Lebwohl, Laura J Savage, Keiichi Yamanaka

Dermatol Ther (Heidelb)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-Term Efficacy of Lebrikizumab Versus Dupilumab in Combination with Topical Corticosteroids in Adults with Moderate-to-Severe Atopic Dermatitis: Matching-Adjusted Indirect Comparison.
Raj Chovatiya, April Armstrong, Leon Kircik, Lluís Puig, Mark G Kirchhof

Dermatol Ther (Heidelb)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal Itch Response in Adults Treated with Dupilumab for Moderate-to-Severe Atopic Dermatitis.
Sonja Ständer, Gil Yosipovitch, Brian S Kim, Martin Steinhoff, April Armstrong

Dermatol Ther (Heidelb)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brodalumab as a Second-Line Therapy in Psoriasis: Rapid Response and Unique Mechanism of Action After Biologic Failure.
Lawrence Green, April Armstrong, George Han, Abby Jacobson

Dermatol Ther (Heidelb)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-17C as a Driver of Inflammation in Psoriasis.
George Han, April Armstrong, James G Krueger, Abby Jacobson

Adv Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin does not decrease the incidence of shoulder arthroplasty in patients with glenohumeral joint osteoarthritis.
Tarek Haj Shehadeh, Jawaad Chaudhry, Ahmed Abdeen, Gary Updegrove, April Armstrong

JSES Rev Rep Tech· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Colors Beneath: More Than a Skin Condition.
Matthew J Yan, Peichi P Chou, Alyssa M Roberts, Charlotte Y Jeong, Nicole Johnsen, April W Armstrong

J Am Acad Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of biologic use on the development of psoriatic arthritis: A population-based study.
Kathleen L Miao, Margaret Y Huang, Lily Guo, Khristina Lung, April W Armstrong

J Eur Acad Dermatol Venereol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Matching-Adjusted Indirect Comparison of the Efficacy of Delgocitinib Cream and Dupilumab in the Treatment of Moderate to Severe Atopic Hand Eczema.
David Cohen, Anthony Bewley, Andreas Wollenberg, H Chih-Ho Hong, April Armstrong

Dermatol Ther (Heidelb)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Joint position statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on routine testing for latent tuberculosis infection prior to and during treatment of psoriasis patients with interleukin 17 or interleukin 23 inhibitors.
Andrew Blauvelt, Bruce E Strober, Guy S Eakin, Leah McCormick Howard, Christy Langan, April W Armstrong

J Am Acad Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is Cumulative Life Course Impairment Considered in Psoriasis Management? A Multinational Survey of People with Psoriasis and Healthcare Professionals.
Raymond Matthews, April W Armstrong, Matthias Augustin, Christopher Baker, José Manuel Carrascosa

Dermatol Ther (Heidelb)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical and patient factors associated with baseplate failures after reverse shoulder arthroplasty: a study by the ASES Complications of RSA Multicenter Research Group.

J Shoulder Elbow Surg· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials.
Tiffany Mayo, Jonathan I Silverberg, April Armstrong, Emma Guttman-Yassky, Andrew Blauvelt

Am J Clin Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis.
Matthias Augustin, April Armstrong, Naiem T Issa, Anne Sohrt Petersen, Rie von Eyben

Dermatol Ther (Heidelb)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic companions: An updated national cross-sectional study of metabolic syndrome comorbidities in outpatient visits for hidradenitis suppurativa.
Elaine J Ma, Alyssa M Roberts, Peichi Chou, Abigail Katz, Charlotte Y Jeong, April W Armstrong

PLoS One· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Working to Mitigate Bias in ABOS Board Certification and Recertification.
Charles L Nelson, April D Armstrong

J Bone Joint Surg Am· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trials.
Linda Stein Gold, April W Armstrong, Robert Bissonnette, Nina Magnolo, Ronald B Vender

Lancet· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis